Literature DB >> 22561871

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.

Volodymyr P Tryndyak1, John R Latendresse, Beverly Montgomery, Sharon A Ross, Frederick A Beland, Ivan Rusyn, Igor P Pogribny.   

Abstract

MicroRNAs (miRNAs) are a class of small, conserved, tissue-specific regulatory non-coding RNAs that modulate a variety of biological processes and play a fundamental role in the pathogenesis of major human diseases, including nonalcoholic fatty liver disease (NAFLD). However, the association between inter-individual differences in susceptibility to NAFLD and altered miRNA expression is largely unknown. In view of this, the goals of the present study were (i) to determine whether or not individual differences in the extent of NAFLD-induced liver injury are associated with altered miRNA expression, and (ii) assess if circulating blood miRNAs may be used as potential biomarkers for the noninvasive evaluation of the severity of NAFLD. A panel of seven genetically diverse strains of inbred male mice (A/J, C57BL/6J, C3H/HeJ, 129S/SvImJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ) were fed a choline- and folate-deficient (CFD) diet for 12weeks. This diet induced liver injury in all mouse strains; however, the extent of NAFLD-associated pathomorphological changes in the livers was strain-specific, with A/J, C57BL/6J, and C3H/HeJ mice being the least sensitive and WSB/EiJ mice being the most sensitive. The morphological changes in the livers were accompanied by differences in the levels of hepatic and plasma miRNAs. The levels of circulating miR-34a, miR-122, miR-181a, miR-192, and miR-200b miRNAs were significantly correlated with a severity of NAFLD-specific liver pathomorphological features, with the strongest correlation occurring with miR-34a. These observations suggest that the plasma levels of miRNAs may be used as biomarkers for noninvasive monitoring the extent of NAFLD-associated liver injury and susceptibility to NAFLD. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561871      PMCID: PMC4281090          DOI: 10.1016/j.taap.2012.04.018

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  39 in total

1.  MicroRNA expression in the livers of inbred mice.

Authors:  Daniel M Gatti; Lu Lu; Robert W Williams; Wei Sun; Fred A Wright; David W Threadgill; Ivan Rusyn
Journal:  Mutat Res       Date:  2011-05-14       Impact factor: 2.433

Review 2.  Human fatty liver disease: old questions and new insights.

Authors:  Jonathan C Cohen; Jay D Horton; Helen H Hobbs
Journal:  Science       Date:  2011-06-24       Impact factor: 47.728

Review 3.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

4.  Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.

Authors:  Verena Bihrer; Mireen Friedrich-Rust; Bernd Kronenberger; Nicole Forestier; Jörg Haupenthal; Ying Shi; Jan Peveling-Oberhag; Heinfried H Radeke; Christoph Sarrazin; Eva Herrmann; Stefan Zeuzem; Oliver Waidmann; Albrecht Piiper
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

5.  Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C.

Authors:  Kazutoyo Morita; Akinobu Taketomi; Ken Shirabe; Kenji Umeda; Hiroto Kayashima; Mizuki Ninomiya; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  Liver Int       Date:  2010-12-30       Impact factor: 5.828

6.  Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.

Authors:  Tania M Welzel; Barry I Graubard; Stefan Zeuzem; Hashem B El-Serag; Jessica A Davila; Katherine A McGlynn
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

7.  Genetic analysis of complex traits in the emerging Collaborative Cross.

Authors:  David L Aylor; William Valdar; Wendy Foulds-Mathes; Ryan J Buus; Ricardo A Verdugo; Ralph S Baric; Martin T Ferris; Jeff A Frelinger; Mark Heise; Matt B Frieman; Lisa E Gralinski; Timothy A Bell; John D Didion; Kunjie Hua; Derrick L Nehrenberg; Christine L Powell; Jill Steigerwalt; Yuying Xie; Samir N P Kelada; Francis S Collins; Ivana V Yang; David A Schwartz; Lisa A Branstetter; Elissa J Chesler; Darla R Miller; Jason Spence; Eric Yi Liu; Leonard McMillan; Abhishek Sarkar; Jeremy Wang; Wei Wang; Qi Zhang; Karl W Broman; Ron Korstanje; Caroline Durrant; Richard Mott; Fuad A Iraqi; Daniel Pomp; David Threadgill; Fernando Pardo-Manuel de Villena; Gary A Churchill
Journal:  Genome Res       Date:  2011-03-15       Impact factor: 9.043

8.  Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Elizabeth M Brunt; David E Kleiner; Kris V Kowdley; Naga Chalasani; Joel E Lavine; Vlad Ratziu; Arthur McCullough
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

9.  Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Authors:  Silvia Cermelli; Anna Ruggieri; Jorge A Marrero; George N Ioannou; Laura Beretta
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

10.  Subspecific origin and haplotype diversity in the laboratory mouse.

Authors:  Hyuna Yang; Jeremy R Wang; John P Didion; Ryan J Buus; Timothy A Bell; Catherine E Welsh; François Bonhomme; Alex Hon-Tsen Yu; Michael W Nachman; Jaroslav Pialek; Priscilla Tucker; Pierre Boursot; Leonard McMillan; Gary A Churchill; Fernando Pardo-Manuel de Villena
Journal:  Nat Genet       Date:  2011-05-29       Impact factor: 38.330

View more
  41 in total

Review 1.  Micro RNAs in the development of non-alcoholic fatty liver disease.

Authors:  Glenn S Gerhard; Johanna K DiStefano
Journal:  World J Hepatol       Date:  2015-02-27

2.  Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Kranti Konganti; Yu-Syuan Luo; Thomas J McDonald; Yasuhiro Iwata; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  J Pharmacol Exp Ther       Date:  2017-02-01       Impact factor: 4.030

3.  Stress of Strains: Inbred Mice in Liver Research.

Authors:  Arlin B Rogers
Journal:  Gene Expr       Date:  2018-08-09

4.  Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

Authors:  Gabor Lendvai; Katalin Jármay; Gizella Karácsony; Tünde Halász; Ilona Kovalszky; Kornélia Baghy; Tibor Wittmann; Zsuzsa Schaff; András Kiss
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.

Authors:  Barbara Borowa-Mazgaj; Aline de Conti; Volodymyr Tryndyak; Colleen R Steward; Leandro Jimenez; Stepan Melnyk; Mulugeta Seneshaw; Faridodin Mirshahi; Ivan Rusyn; Frederick A Beland; Arun J Sanyal; Igor P Pogribny
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

6.  Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.

Authors:  Robert Vincent; Arun Sanyal
Journal:  Curr Pathobiol Rep       Date:  2014-09-01

7.  Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis.

Authors:  John D Clarke; Tatiana Sharapova; April D Lake; Eric Blomme; Jonathan Maher; Nathan J Cherrington
Journal:  J Appl Toxicol       Date:  2013-11-12       Impact factor: 3.446

8.  Acetaminophen-induced acute liver injury in HCV transgenic mice.

Authors:  Takeki Uehara; Oksana Kosyk; Emmanuelle Jeannot; Blair U Bradford; Katherine Tech; Jeffrey M Macdonald; Gary A Boorman; Saurabh Chatterjee; Ronald P Mason; Stepan B Melnyk; Volodymyr P Tryndyak; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-29       Impact factor: 4.219

Review 9.  MicroRNAs in liver disease.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-21       Impact factor: 46.802

Review 10.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.